INTECH BIOPHARM LTD.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 82
- Market Cap
- -
Efficacy Study of SYN006 HFA MDI in Asthma Patients
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- Drug: Budesonide/Procaterol, 180/10mcg X1Drug: Budesonide/procaterol 180/10 mcg X 2
- First Posted Date
- 2014-06-13
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 39
- Registration Number
- NCT02162784
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
🇨🇳Chung Shan Medical University Hospital, TaiChung, Taiwan
© Copyright 2025. All Rights Reserved by MedPath